BIT 2.70% 3.8¢ biotron limited

Ann: Presentation to Investors, page-9

  1. 896 Posts.
    lightbulb Created with Sketch. 52
    Maybe....BUT:

    Data from the Phase 2 HIV-1 trial to be presented at key conferences, and also shared with potential partners, during late 2018/early 2019
    • The successful results from this study are expected to facilitate commercialisation negotiations with these parties

    Do you honestly believe the data will be presented to peers at these conferences, let alone shared with potential partners if it wasn't robust?
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.